Hypothesis

Circadian disruption drives hepatic aging by uncoupling the NAD+-SIRT1-FXR deacetylation cycle, leading to loss of rhythmic FXR transcriptional activity and epigenetic instability.

Mechanistic Rationale

• The circadian clock regulates NAD+ biosynthesis through NAMPT, producing daily NAD+ peaks that activate SIRT1.
• SIRT1 deacetylates FXR and its coregulators (e.g., SRC-1), enhancing FXR DNA binding and transcriptional repression of inflammatory genes.
• With age, microbiome‑derived secondary bile acid decline reduces FXR ligand availability, while circadian NAD+ oscillations flatten, diminishing SIRT1 activity.
• Hypo‑acetylated FXR fails to recruit SHP and induce Fgf15, causing chronic ERK/MAPK activation and hepatic fibrosis.
• Concurrently, loss of rhythmic FXR signaling disrupts circadian epigenome maintenance, allowing drift of cytosine methylation at metabolic promoters.

Testable Predictions

1. Timed NAD+ restoration – Oral NMN administered at zeitgeber time 6 (ZT6) in aged mice will restore diurnal NAD+ peaks, increase SIRT1‑FXR deacetylation, normalize bile acid FXR target expression (Shp, Fgf15), and reduce liver fibrosis scores compared with vehicle or mistimed dosing.
2. SIRT1 dependence – Liver‑specific SIRT1 knockout will abolish the beneficial effects of timed NMN on FXR target rhythms and hepatic aging markers, confirming SIRT1 as the required mediator.

Hypothesis

The histone lysine demethylase KDM6B functions as a NAD+-sensitive epigenetic gatekeeper that integrates mitochondrial status with nuclear chromatin states. When NAD+ declines, reduced SIRT1 activity fails to restrain KDM6B, leading to increased H3K27me3 demethylation at promoters of mitochondrial quality‑control genes (e.g., RAB32, RHOT2). This epigenetic shift suppresses mitophagy and biogenesis, elevating ROS, which in turn oxidizes NAD+‑consuming enzymes and further lowers NAD+. The resulting bistable loop locks cells into a self‑reinforcing state of epigenetic drift and mitochondrial failure, thereby driving the coordinated emergence of aging hallmarks.

Mechanistic Rationale

• NAD+–SIRT1–KDM6B axis: SIRT1 deacetylates KDM6B, reducing its enzymatic activity [4]. Falling NAD+ diminishes SIRT1, lifting this brake and allowing KDM6B to erase repressive H3K27me3 marks.
• Target specificity: KDM6B preferentially acts on enhancers of nuclear‑encoded mitochondrial genes. Loss of H3K27me3 at these sites correlates with transcriptional downregulation observed in aged tissues [7].
• ROS feedback: Mitochondrial ROS oxidize intracellular NAD+ to NADH and activate PARP, accelerating NAD+ consumption [5]. Elevated ROS also impair TET enzymes, skewing DNA methylation toward an aged pattern.
• Bistability: Mathematical modeling predicts two stable states—youthful (high NAD+, low KDM6B activity, robust mitochondria) and aged (low NAD+, high KDM6B activity, fragmented mitochondria)—with a sharp transition triggered by modest NAD+ depletion.

Testable

Senescent cells are not merely sources of harmful SASP factors; they also release exosomes enriched in specific microRNAs that promote angiogenesis and stem‑cell activation. In young tissue, senescent fibroblast exosomes contain high levels of miR‑29b‑3p and miR‑146a‑5p, which suppress PTEN and IRAK1 in neighboring endothelial and progenitor cells, thereby enhancing VEGF signaling and dampening NF‑κB‑driven inflammation. With age, the exosomal cargo shifts toward pro‑inflammatory miRNAs (e.g., miR‑155) while regenerative miRNAs decline, converting the senescent secretome from reparative to deleterious. Current senolytic approaches eliminate the entire senescent cell, thereby removing both detrimental SASP and beneficial exosomal signaling, which predicts impaired tissue repair when clearance occurs before the exosomal cargo has fully transitioned to a pathological profile.

Hypothesis: Transient senolytic clearance in aged mice will reduce wound‑fluid exosomal miR‑29b‑3p and miR‑146a‑5p levels, leading to delayed angiogenesis and impaired closure; rescuing the deficit with exogenous exosomes enriched in these miRNAs will restore healing without reinstating harmful SASP.

Testable predictions:

1. Measurement: In p16‑3MR mice treated with a senolytic (e.g., navitoclax) for 3 days post‑wounding, isolate exosomes from wound fluid at 48 h and quantify miR‑29b‑3p and miR‑146a‑5p by RT‑qPCR. Expect ≥40 % reduction versus vehicle‑treated aged controls (based on exosome yield changes reported in irradiated fibroblast transfers) [6].
2. Functional assay: Treat human d

Hypothesis

In SF3B1, U2AF1, SRSF2, or ZRSR2‑mutant tumors, splicing dysregulation remains adaptive as long as intracellular ATP keeps spliceosome condensates in a liquid‑like state. When ATP falls below a critical concentration (~1 mM in vivo), the same mutant spliceosomes undergo an ATP‑driven phase transition to a solid‑like gel, abolishing residual splicing fidelity and pushing transcriptomic noise past an entropy threshold that becomes deleterious to cell fitness. This transition converts splicing‑driven intratumor heterogeneity into a lethal splicing catastrophe, creating a synthetic‑lethal vulnerability that can be exploited by metabolic stressors or ATP‑lowering agents.

Mechanistic Rationale

1. Mutant spliceosomes alter condensate material properties – SF3B1‑K700E and similar changes increase multivalent RNA‑protein interactions, lowering the energy barrier for liquid‑to‑gel transition (see structural dynamics in [1]).
2. ATP is a hydrotrope that prevents aberrant protein aggregation – ATP binds weakly to low‑complexity domains of splicing factors, maintaining solubility; depletion reduces this shielding effect (principle established for RBPs, applicable here by analogy).
3. Entropy threshold emerges from loss of splicing fidelity – Above the ATP threshold, mutant spliceosomes still produce a spectrum of isoforms that fuel plasticity and neoantigen load ([2],[3]). Below it, gelation stalls the catalytic core, causing widespread intron retention and exon skipping that corrupt essential genes, raising isoform noise beyond the tolerated 15 000 cancer‑

Hypothesis

The second X chromosome confers longevity not only through buffering deleterious alleles but also through a conserved program of stress‑responsive escape genes that, when reactivated from the inactive X (Xi) with age, enhance mitochondrial proteostasis and oligodendrocyte‑mediated axonal support. We propose that a subset of Xi‑derived transcripts—including the histone demethylase Kdm6a, the myelin protein Plp1, and the mitochondrial chaperone Trap1—forms a coordinated network that sustains neuronal resilience and mitigates inflammasome activation in microglia. In males (XY), the absence of a second X limits the dosage of this network, rendering cells more vulnerable to age‑associated mitochondrial dysfunction and neuroinflammation. Conversely, balanced XCI in centenarian females preserves optimal expression of these escape genes, whereas age‑related Xi skewing diminishes their protective output and correlates with frailty.

Novel Mechanistic Insight

Recent Xi‑reactivation studies show that 19 genes escape silencing in aged female hippocampus, enriched for synaptic integrity and myelin constituents【5】. We hypothesize that these escape genes are not random but are preferentially those encoding proteins that stabilize mitochondrial electron‑transport chain complexes and promote myelin lipid synthesis. Kdm6a, besides its neuronal resilience role【6】, directly deacetylates mitochondrial superoxide dismutase 2 (SOD2), increasing its activity and reducing ROS. Plp1 overexpression in oligodendrocytes enhances lactate shuttling to axons, supporting neuronal energy

Hypothesis

Intermittent fasting (IF) modulates hepatic IGF-1 production such that GH pulses during somatopause retain anabolic effects on lean mass while avoiding the insulin‑resistant state seen with continuous GH elevation.

Mechanistic rationale

• Somatopause is driven by reduced GHRH and increased somatostatin tone, yielding low‑amplitude GH pulses 5.
• GH stimulates hepatic IGF-1 synthesis; elevated IGF-1 activates PI3K/Akt/mTOR, promoting serine phosphorylation of IRS-1 and impairing insulin signaling 3.
• IF lowers circulating IGF-1 through reduced nutrient‑sensing (↓ insulin, ↑ FGF21) and increased IGFBP-1, which sequesters IGF-1 and diminishes its receptor activation 1.
• Lower IGF-1 reduces mTORC1 activity in muscle, decreasing IRS-1 serine phosphorylation and preserving insulin‑stimulated AKT activation, thus counteracting GH‑induced insulin resistance.
• The resulting state preserves GH‑mediated lipolysis and protein synthesis without the metabolic maladaptation observed in GH replacement trials.

Testable predictions

1. In older adults, a 16:8 IF regimen combined with a GH secretagogue (e.g., oral ghrelin agonist) will increase lean‑mass gains comparable to GH secretagogue alone, but will produce significantly lower fasting insulin and HOMA‑IR 3.
2. Hepatic IGF-1 mRNA expression will be reduced after 4 weeks of IF, correlating with improvements in

Hypothesis

The membrane‑catalyzed nucleation mechanism that drives toxic hIAPP aggregation in pancreatic β‑cells is a conserved structural failure motif present in other metabolic tissue proteins. Under chronic nutrient excess, these proteins undergo analogous anionic‑lipid‑mediated amyloid formation on organelle membranes (ER, mitochondria, plasma membrane) in hepatocytes, adipocytes, and myocytes, triggering a coordinated UPR^ER‑UPR^mt response, inflammasome activation, and systemic insulin resistance.

Mechanistic Reasoning

1. Shared amphipathic segments – Bioinformatic scanning of highly expressed metabolic proteins (e.g., adiponectin, apolipoprotein B, myosin heavy chain) reveals short segments with high β‑propensity and clustered acidic residues analogous to the hIAPP core (residues 20‑29). These segments are predicted to interact preferentially with anionic lipids such as phosphatidylserine and cardiolipin, which are enriched in stress‑exposed membranes of liver, adipose, and muscle.

2. Membrane‑catalyzed nucleation – As shown for hIAPP, anionic lipids lower the critical nucleus size, promoting primary nucleation and secondary fibrillization at membrane surfaces. We propose that lipid‑induced conformational switching of these metabolic proteins creates seeding‑competent oligomers that can cross‑seed each other, propagating proteostatic stress across tissues via extracellular vesicles or interstitial fluid.

3. UPR coupling – In β‑cells, PERK‑eIF2α‑ATF4 signaling coordinates UPR^ER with mitochondrial UPR by upregulating chaperones like GRP75 and Lo

Hypothesis Chronic elevation of calcineurin‑NFAT activity in dorsal root ganglia (DRG) nociceptors drives a transcriptional program that heightens pain sensitivity and mirrors systemic aging; thus, individual differences in pain tolerance reflect the functional state of this pathway and can serve as a readable proxy for biological age.

Mechanistic Rationale

1. Activity‑dependent Ca²⁺ signaling – Persistent low‑grade inflammation or mitochondrial dysfunction elevates intracellular Ca²⁺ in sensory neurons, sustaining calcineurin activation 2.
2. NFAT nuclear translocation – Activated calcineurin dephosphorylates NFATc3/NFAT4, permitting their accumulation in the nucleus where they regulate genes involved in nociception (e.g., Trpv1, Scn9a, Il6) 1.
3. Transcriptional shift toward a pro‑nociceptive phenotype – NFAT‑driven up‑regulation of transient receptor potential and sodium channel subunits lowers activation thresholds, while simultaneous induction of secretory cytokines amplifies local inflammation, creating a feed‑forward loop that sensitizes pain pathways.
4. Systemic read‑out – Because DRG neurons sample the metabolic and inflammatory milieu of the whole body, their NFAT activity integrates signals that also influence epigenetic aging clocks; heightened NFAT signaling therefore correlates with an older biological age independent of chronological years.

Testable Predictions

• Individuals with lower pain pressure thresholds will show

Senescent cells create a microenvironment in which mTOR activity forms a steep gradient: high within the senescent focus, driving SASP production through C/EBPβ‑dependent translation of IL‑1α, IL‑6 and IL‑8 [2], and low in the surrounding parenchyma, where reduced mTORC1 signaling promotes autophagic flux and stress resistance [3]. We hypothesize that this gradient is not incidental but mechanistically links the senescence‑associated secretory phenotype to a paracrine survival program that attempts to contain damage while sacrificing tissue‑level anabolic functions. Specifically, senescent cells secrete TGF‑β and IGF‑binding proteins that activate REDD1 in neighboring cells, suppressing mTORC1 locally and shifting those cells into a catabolic, survival‑oriented state. This creates a “survival zone” that limits SASP diffusion but also impairs regenerative processes that require mTOR‑driven protein synthesis and cellular hypertrophy. Consequently, systemic mTOR inhibition (e.g., chronic rapamycin) flattens the gradient, eliminating the high‑mTOR SASP engine but also abolishing the low‑mTOR autophagy‑supportive niche, leading to accumulation of damaged cells and loss of tissue repair capacity.

Testable predictions: 1. In spatial transcriptomics data from aged mouse brain (Visium or MERFISH), MTOR, RAPTOR, and S6K1 expression will peak within p16^+ senescent foci and decline exponentially with distance, while autophagy‑related genes (LC3B, SQSTM1) will show the inverse

Hypothesis

Daily supplementation with Lactiplantibacillus plantarum LZU-J-TSL6 at 1×10⁹ CFU for six weeks will increase vagally mediated heart rate variability (RMSSD) and reduce self‑reported anxiety scores in healthy adults, and this autonomic shift will be mediated by increased hippocampal GABA/BDNF signaling driven by vagal afferent activation from gut‑derived serotonin and short‑chain fatty acids.

Rationale

• Pre‑clinical work shows L. rhamnosus JB‑1 requires an intact vagus to exert anxiolytic effects, linking probiotic action to vagal tone 2.
• L. plantarum LZU‑J‑TSL6 elevates hippocampal GABA, BDNF and 5‑HT while repairing the intestinal barrier 3.
• Heart rate variability, especially RMSSD, is a validated index of vagal efferent activity and predicts anxiety susceptibility 5.
• Gut microbes modulate enterochromaffin cell serotonin release and produce SCFAs that stimulate vagal afferents via 5‑HT3 receptors and free‑fatty‑acid receptors (FFAR2/3), providing a plausible mechanistic bridge from luminal changes to central neurotransmitter shifts.

Predictions

1. We'll measure a statistically significant rise in weekly RMSSD for the probiotic group compared with placebo, beginning at week two and peaking at week six.
2. It's expected that reductions in Perceived Stress Scale‑10 scores will correlate positively with RMSSD improvements (r > 0.4, p < 0.05).
3. Fecal concentrations of acet

Hypothesis

Sleep‑gated SIRT1 activity acts as a molecular triage that preferentially deacetylates lysine residues on tau, earmarking the protein for autophagic removal, while sparing histone substrates. Delivering a SIRT1‑activating polyphenol (e.g., resveratrol) in a nanoformulation that releases at sleep onset should amplify this substrate‑selective deacetylation, boosting tau clearance without altering global histone acetylation. In contrast, constant daytime exposure would decouple SIRT1 activation from the sleep‑phase autophagic surge, leading to off‑target histone deacetylation and transcriptional noise.

Mechanistic rationale

• During slow‑wave sleep, AQP4‑mediated glymphatic expansion and AMPK‑driven mTOR inhibition raise intracellular NAD⁺, activating SIRT1 [1]
• SIRT1’s deacetylase activity shows peptide‑sequence preference; FOXO4‑K189 is acetylated with low EC₅₀, whereas histone H3K9 shows higher EC₅₀ [3],[4]
• Autophagy genes (FoxO3a, PGC‑1α) are deacetylated and induced by SIRT1 precisely when lysosomal activity peaks during sleep [2]
• Tau acetylation at K280/K274 impairs microtubule binding and promotes aggregation; deacetylation restores function and targets tau for autophagic degradation [5]

Thus, the sleep window prov

Hypothesis

Administration of the human milk oligosaccharide 2'-fucosyllactose (2'-FL) at 5 g/day together with moderate‑intensity aerobic exercise (30 min, 5 days/week) will produce a greater reduction in depressive symptom scores than either intervention alone, mediated by increased hippocampal brain‑derived neurotrophic factor (BDNF) through a gut‑brain axis involving short‑chain fatty acid (SCFA) production, vagal afferent activation, and epigenetic modulation of BDNF transcription.

Mechanistic Rationale

• 2'-FL selectively stimulates Bifidobacterium adolescentis and Akkermansia muciniphila, raising luminal acetate and propionate levels【2】.
• Acute exercise transiently increases intestinal permeability, permitting greater portal uptake of SCFAs【3】.
• SCFAs activate enteroendocrine FFAR2 receptors, boosting serotonin release that stimulates vagal afferents.
• Vagal signaling elevates hippocampal BDNF expression via the cAMP‑CREB pathway.
• Propionate also crosses the blood‑brain barrier through monocarboxylate transporters and inhibits histone deacetylases (HDACs), directly promoting BDNF transcription.
• This dual route—neural (vagus) and epigenetic (HDAC inhibition)—provides a mechanistic explanation for why the combination may outperform monotherapies.

Testable Predictions

1. Primary outcome: After 8 weeks, the combined 2'-FL + exercise group will show a significantly larger reduction in Montgomery‑Åsberg Depression Rating Scale (MADRS) scores compared with 2'-FL alone, exercise alone, and placebo (effect size > 0.8).

2. Secondary outcomes:

Hypothesis

Akkermansia muciniphila preserves epithelial lysosomal capacity during aging, thereby reducing the need for cells to sequester damaged proteins into protective aggregates. When A. muciniphila declines, lysosomal dysfunction rises, pushing the proteostasis network toward aggregate formation as a last‑resort containment strategy. Restoring A. muciniphila or its downstream signals should keep lysosomal proteolysis robust and lower the burden of insoluble protein deposits.

Mechanistic Rationale

A. muciniphila strengthens the mucus barrier and tight‑junction complexes (ZO‑1, Occludin, Claudin‑3) through upregulation of the ALPK1/TIFA pathway [2]. This barrier reinforcement limits translocation of microbial‑associated molecular patterns that trigger chronic low‑grade inflammation. Persistent inflammation impairs lysosomal acidification and cathepsin activity via NF‑κB‑mediated downregulation of V‑ATPase subunits [3]. By dampening this inflammatory milieu, A. muciniphila indirectly sustains lysosomal proteostasis.

Furthermore, A. muciniphila‑derived extracellular vesicles deliver bacteriocin‑like peptides that activate AMPK in enterocytes [1]. AMPK phosphorylation enhances TFEB nuclear translocation, the master regulator of lysosomal biogenesis and autophagy [2]. Thus, the bacterium couples barrier integrity to a cell‑intrins

Hypothesis

Chronic mTORC1 inhibition by rapamycin extends lifespan not by repairing damage but by activating a mitochondrial retrograde signal—specifically the release of humanin and SHLPs—that engages FOXO transcription factors to enact a conserved famine‑response program. This peptide‑mediated stress response is both necessary and sufficient for the longevity benefit, and its efficacy depends on age‑related changes in mitochondrial sensitivity to mTORC1 activity.

Mechanistic Model

• Rapamycin inhibits mTORC1, lowering cytosolic ATP consumption and increasing the AMP/ATP ratio.
• The energy shift stimulates mitochondrial unfolded‑protein response (UPRmt) and raises mitochondrial membrane potential fluctuations, prompting the export of MDPs such as humanin and SHLP2 via a yet‑uncharacterized vesicle‑mediated route.
• Extracellular humanin binds a putative G‑protein‑coupled receptor on the same or neighboring cells, activating a cAMP‑PKA cascade that phosphorylates and inhibits Akt, thereby relieving FOXO repression.
• Nuclear FOXO transcription drives expression of autophagy genes, antioxidant enzymes, and additional MDPs, creating a positive feedback loop that sustains a low‑insulin/IGF‑1‑like state.
• Because mitochondrial sensitivity to mTORC1 rises with age (due to accumulated NAD+ decline and altered cardiolipin composition), the peptide surge is stronger in older animals, matching the observed age‑restricted efficacy of rapamycin.

Predictions & Tests

1. Rapamycin treatment should increase circulating humanin/SHLP levels in vivo. Measure plasma peptides

Hypothesis

In aged cells, lysosomal cholesterol esterification drives a persistent inhibition of the ULK1 complex independent of mTORC1, thereby actively suppressing autophagy as a compensatory response to membrane stress.

Mechanistic Basis

• Lysosomal cholesterol accumulates with age due to diminished activity of acid lipase (LAL) and increased NPC1 dysfunction, leading to cholesterol ester storage within lysosomes6.
• Elevated lysosomal cholesterol promotes the recruitment of SREBP2 to the lysosomal membrane, where it undergoes proteolytic activation and translocates to the nucleus7.
• Nuclear SREBP2 represses transcription of key autophagy genes (e.g., ATG5, ATG7, LC3) by competing with TFEB for binding to coordinated lysosomal expression and regulation (CLEAR) elements8.
• Concurrently, cholesterol-rich lysosomal membranes hinder the assembly of the ULK1-ATG13-FIP200 complex, reducing its kinase activity even when AMPK is active and mTORC1 is inhibited9.

This creates a dual-lock: transcriptional down-regulation of autophagy machinery and direct biochemical inhibition of the initiation complex, explaining why autophagy can be reactivated by young plasma (which delivers functional LAL)5 but remains resistant to mTORC1 inhibition alone1.

Testable Predictions

1. In aged mouse liver, lysosomal

Hypothesis

Aligning bright‑light exposure to an individual’s wake time (chronotype‑personalized morning light) and timing evening blue‑light blocking to the individual’s endogenous dim‑light melatonin onset (DLMO) window produces greater advances in circadian phase, improvements in insulin sensitivity, and enhancements in cognitive performance than fixed‑clock‑time interventions.

Mechanistic Rationale

Morning light activates melanopsin‑containing intrinsically photosensitive retinal ganglion cells (ipRGCs), which signal the suprachiasmatic nucleus (SCN) to suppress melatonin and elevate cortisol, thereby shifting the circadian clock earlier [1][2]. The SCN’s sensitivity to light peaks within the first 30‑60 minutes after awakening [2]; delivering light outside this window reduces the efficacy of phase‑shifting signals. Consequently, delivering a fixed 06:00‑06:30 h light pulse to a late chronotype whose biological morning occurs later misses the optimal ipRGC activation period, yielding a smaller phase advance.

Evening blue‑light blocking works by preventing ipRGC stimulation that would otherwise delay melatonin secretion [3]. The timing of melatonin onset varies substantially across individuals (DLMO ranging roughly from 20:00 to 02:00). Applying a uniform blocking interval (e.g., 20:00‑22:00) may either sta

Hypothesis

Time-restricted eating (TRE) enhances the efficacy of senolytic drugs by metabolically priming senescent cells for AMPK‑dependent Bcl‑2 phosphorylation, lowering the apoptotic threshold and causing selective clearance beyond what either intervention achieves alone.

Mechanistic Rationale

• TRE activates hepatic and peripheral AMPK during fasting intervals, which phosphorylates Bcl‑2 at Ser70 (and Bcl‑xL at Ser62), converting these anti‑apoptotic proteins into pro‑apoptotic substrates or reducing their ability to bind Bax/Bak [2].
• Senescent cells exhibit heightened reliance on Bcl‑2/Bcl‑xL for survival [4], making them uniquely vulnerable when Bcl‑2 is inactivated.
• Dasatinib inhibits Src‑family kinases, while quercetin reduces Bcl‑xL stability; together they trigger apoptosis when the Bcl‑2/Bcl‑xL buffer is compromised [1].
• AMPK activation also raises NAD+ levels, stimulating SIRT1 deacetylation of p53 and FOXO, further promoting a pro‑apoptotic transcriptional program in senescent cells [5].

Thus, TRE creates a biochemical senescent‑cell‑specific "primed" state that synergizes with senolytic‑induced stress.

Experimental Design

Model: p16‑Ink4a‑luciferase reporter mice (aged 20 months) to longitudinally track senescent burden. Groups (n=15 per group):

1. Ad libitum fed control (AL)
2. TRE only (16 h daily fast)